Botanical species · safety record

Portulaca oleracea

The EFSA Compendium of Botanicals holds 9 constituent measurements and 7 adverse-effect records for Portulaca oleracea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Portulaca oleracea L.

9Constituent measurements

7Safety records

6Cited sources

69Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 69 licensed products naming Portulaca oleracea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aerial parts
Herb
Herb top
New material
Seed(s)
Whole plant
standardized extract

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Nitrate	Leaves	Solvent extraction	319 Milligram/100 gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Oxalic acid	Leaves	Solvent extraction	770 Milligram/100 gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Alkaloids	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Cyanogenic glycosides	Unspecified	Solvent extraction	≤ 1371.85 Microgram/gram	Chromatographic tests	No resolvable identifier
Cyanogenic glycosides	Unspecified	Solvent extraction	≥ 1013.39 Microgram/gram	Chromatographic tests	No resolvable identifier
Dopamine	Leaves	Solvent extraction	0.074 Percent	Unspecified	No resolvable identifier
Dopamine	Seed	Solvent extraction	0.054 Percent	Unspecified	No resolvable identifier
Saponins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Aerial part of plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Neurologic	Aerial part of plants	Solvent extraction	House mouse (as animal)	Acute toxicity	No resolvable identifier
Other toxicities	—	Aerial part of plants	Solvent extraction	House mouse (as animal)	Acute toxicity	No resolvable identifier
Pulmonary and cardiac	Respiratory	Unspecified	Solvent extraction	Human (as organism)	Case report	No resolvable identifier
Pulmonary and cardiac	Respiratory	Unspecified	Solvent extraction	Human (as organism)	Case report	No resolvable identifier
Reproductive	—	Unspecified	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier
Reproductive	Urogenital	Aerial part of plants	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier
Reproductive	Urogenital	Aerial part of plants	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Shafi, S., Tabassum, N. Acute oral toxicity and hypoglycaemic study of ethanolic extract of Portulaca oleracea (whole plant) in swiss albino mice. International journal of pharmacy and pharmaceutical sciences, 2013, vol. 5, no. SUPPL.4, p. 389-393.
Oyedeji, K.O., Bolarinwa, A.F., Adegoke, A.O. Evaluation of antifertility and teratogenic effects of chromatographic fractions of Portulaca oleracea in male and female albino rats. International journal of pharmacy and pharmaceutical sciences, 2013, vol. 5, no. 3, p. 440-444.
Londonkar, R., Nayaka, H.B. Evaluation of anti implantation and abortificient properties of Portulaca oleracea L. In albino rats. International journal of pharma and bio sciences, 2011, vol. 2, no. 4, p. 501-508.
Mirabzadeh, Mehran., Sahraee, Zahra., Rahimi, Roja. Evaluation of adverse events reported in Traditional Iranian Medicine following administration of aqueous extract of Herba Portulacae Oleraceae seed . Journal of traditional chinese medicine, 2013, vol. 33, no. 4, p. 535-537.
Guil, JL., Rodriguez-Garcia, I., Torija, E. Nutritional and toxic factors in selected wild edible plants. PLANT FOODS FOR HUMAN NUTRITION, 1997, vol. 51, no. 2, p. 99-107. DOI
Cho, Hye-Jeon., Do, Byung-Kyung., Shim, Soon-Mi., Kwon, Hoonjeong., Lee, Dong-Ha., Nah, Ahn-Hee., Choi, Youn-Ju., Lee, Sook-Yeon. Determination of cyanogenic compunds in edible plants by ion chromatography. Toxicological research (seoul, republic of korea), 2013, vol. 29, no. 2, p. 143-147.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature